RxDoctor Payments Data

Viviany Taqueti

Cardiovascular Disease · Boston, MANPI 1891990446

Payments from drug & device makers

$88,104in general payments, 2019–2025

Across 23 payments — averaging $3830.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$65K
  • Abbott$9K
  • Pfizer$8K
  • Genetesis, Inc.$5K
  • Heartflow, Inc.$222

What the payments were for

  • Consulting fees$22,88399%
  • Food & beverage$2221%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead1$65,000
Abbott1$9,188
Pfizer18$8,470
Genetesis, Inc.2$5,225
Heartflow, Inc.1$222

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$88,104 in reported general payments places this provider in the 85th percentile of 750 cardiovascular disease providers in Massachusetts.

See all cardiovascular disease providers in Massachusetts

Medicare billing

Part B allowed, 2024
$56,865
Medicare patients
499
Services billed
1,526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →